RESULTS	Fasting and postprandial triglyceride ( TG ) levels were significantly lower following PGZ therapy ( fasting : -0.35 vs 0.44 mmol/L ; p < 0.04 ; postprandial AUC-TG : -195.6 vs 127.9 mmol/L/min ; p < 0.02 ) associated with changes in VLDL-2-TG ( -0.10 vs 0.21 mmol/L ; p = 0.23 ) and VLDL-3-TG ( 0.0 vs 0.34 mmol/L ; p < 0.04 ) .\